IL23R and psoriasis: They made a study on a smaller number of pediatric IBD patients, suggesting that IL23R genes (rs10489628, rs10789229, and rs1343151) were more prevalent in patients with psoriasis after infliximab therapy than CD patients treated also by infliximab but who did not develop psoriasis [69].